Chagas disease in the 21st Century: a public health success or an emerging threat?
Parasite, 21 (2014) 11
Published online: 2014-03-10
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Identification of Antifungal Agents AR-12 and Fosmanogepix as Anti-Trypanosoma cruzi Drugs through an Enhanced Fluorogenic β-Galactosidase Phenotypic Screening Assay
Mercedes Didier Garnham, Franco Agustín Agüero, Juan Carlos Ramírez, Fernán Agüero and Emir Salas-SarduyACS Infectious Diseases 12 (2) 724 (2026)
https://doi.org/10.1021/acsinfecdis.5c00900
Fighting Strategies Against Chagas’ Disease: A Review
Andrea Hernández-Flores, Debora Elías-Díaz, Bernadeth Cubillo-Cervantes, Carlos N. Ibarra-Cerdeña, David Morán, Audrey Arnal and Andrea ChavesPathogens 14 (2) 183 (2025)
https://doi.org/10.3390/pathogens14020183
Stable colonization of the kissing bug Rhodnius prolixus by Trypanosoma cruzi Y strain
Ruby E. Harrison, Kevin J. Vogel, Ronald Drew Etheridge and Claudia Ida BrodskynPLOS Neglected Tropical Diseases 19 (3) e0012906 (2025)
https://doi.org/10.1371/journal.pntd.0012906
Treatment options applied to the preclinical studies using animal models for Chagas Disease: a systematic review and meta-analysis
Laura Yesenia Machaca-Luque, Mayron Antonio Candia-Puma, Brychs Milagros Roque-Pumahuanca, Haruna Luz Barazorda-Ccahuana, Luis Daniel Goyzueta-Mamani, Alexsandro Sobreira Galdino, Ricardo Andrez Machado-de-Ávila, Rodolfo Cordeiro Cordeiro Giunchetti, Eduardo Antonio Ferraz Coelho and Miguel Angel Chavez-FumagalliF1000Research 13 885 (2025)
https://doi.org/10.12688/f1000research.150723.3
Treatment options applied to the preclinical studies using animal models for Chagas Disease: a systematic review and meta-analysis
Laura Yesenia Machaca-Luque, Mayron Antonio Candia-Puma, Brychs Milagros Roque-Pumahuanca, Haruna Luz Barazorda-Ccahuana, Luis Daniel Goyzueta-Mamani, Alexsandro Sobreira Galdino, Ricardo Andrez Machado-de-Ávila, Rodolfo Cordeiro Cordeiro Giunchetti, Eduardo Antonio Ferraz Coelho and Miguel Angel Chavez-FumagalliF1000Research 13 885 (2025)
https://doi.org/10.12688/f1000research.150723.2
Prevalence and diagnostic accuracy of different diagnostic tests for Chagas disease in an indigenous community of the Paraguayan Chaco
Sofia Ardiles-Ruesjas, Vidalia Lesmo, Valeria González-Romero, Zully Cubilla, Lilian Chena, Claudia Huber, María José Rivas, Patricia Saldaña, Adrián Carrascosa, Susana Méndez, Sergi Sanz, Sören L. Becker, Julio Alonso-Padilla, Irene Losada and Deborah Bittencourt Mothé FragaPLOS Neglected Tropical Diseases 19 (2) e0012861 (2025)
https://doi.org/10.1371/journal.pntd.0012861
(2025)
https://doi.org/10.1101/2025.10.01.679864
Impact of Structural Barriers on Undocumented Migrants at Risk of Chagas Disease in Switzerland: A Double Burden of Neglect
Elise RappLatin American Perspectives 52 (1) 234 (2025)
https://doi.org/10.1177/0094582X241308853
Optimization of benzenesulfonyl derivatives as anti-Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantum
Guilherme Freitas de Lima Hercos, Mariza Gabriela Faleiro de Moura Lodi Cruz, Ana Clara Cassiano Martinho, Daniela de Melo Resende, Danilo Farago Nascimento, Paula Derksen Macruz, Eduardo Jorge Pilau, Silvane Maria Fonseca Murta and Celso de Oliveira Rezende JúniorBioorganic & Medicinal Chemistry 105 117736 (2024)
https://doi.org/10.1016/j.bmc.2024.117736
Unveiling the overlooked: Current and future distribution dynamics of kissing bugs and palm species linked to oral Chagas disease transmission
Mayara M. Picanço, Raul Narciso C. Guedes, Ricardo S. da Silva, Cleber Galvão, Philipe Guilherme C. Souza, Alice B. Barreto, Letícia Caroline da S. Sant'Ana, Pedro Henrique Q. Lopes and Marcelo C. PicançoActa Tropica 258 107367 (2024)
https://doi.org/10.1016/j.actatropica.2024.107367
Synthesis and in vitro biological activity of chalcone derivatives as potential antiparasitic agents
Koketso J. Setshedi, Richard M. Beteck, Kayhan Ilbeigi, Dorien Mabille, Guy Caljon and Lesetja J. LegoabeMedicinal Chemistry Research 33 (6) 977 (2024)
https://doi.org/10.1007/s00044-024-03235-x
Microencapsulation of Theobroma cacao L polyphenols: A high-value approach with in vitro anti-Trypanosoma cruzi, immunomodulatory and antioxidant activities
Laura Vargas-Munévar, Juan Borja-Fajardo, Angélica Sandoval-Aldana, Wendy Quintero García, Erika Moreno Moreno, Juan Camilo Henriquez, Elena Stashenko, Liliana Torcoroma García and Olimpo García-BeltránBiomedicine & Pharmacotherapy 173 116307 (2024)
https://doi.org/10.1016/j.biopha.2024.116307
Editorial: Neglected tropical diseases: tackling the challenges of a global world
Armanda Rodrigues and Gabriela Santos-GomesFrontiers in Toxicology 6 (2024)
https://doi.org/10.3389/ftox.2024.1417438
Chagas disease as an underrecognized cause of stroke: implications for public health
Jorge Vásconez-González, Camila Miño, Camila Salazar-Santoliva, Melissa Villavicencio-Gomezjurado and Esteban Ortiz-PradoFrontiers in Medicine 11 (2024)
https://doi.org/10.3389/fmed.2024.1473425
Development of a Colorimetric Loop-Mediated Isothermal Amplification Assay for the Detection of Trypanosoma cruzi in Low-Resource Settings
Taylor J. Moehling, Myla D. Worthington, Pui-Yan G. Wong, Season S. Wong and Robert J. MeagherDiagnostics 14 (11) 1193 (2024)
https://doi.org/10.3390/diagnostics14111193
(2024)
https://doi.org/10.1101/2024.02.18.24302989
26 (2024)
https://doi.org/10.5772/intechopen.112774
Structure–Activity Relationships of Novel N -Imidazoylpiperazines with Potent Anti- Trypanosoma Cruzi Activity
Rocío Marisol Espinoza-Chávez, Celso de Oliveira Rezende Júnior, Mariana Laureano de Souza, Ivani Pauli, Marilia Valli, Leonardo Luiz Gomes Ferreira, Rafael Consolin Chelucci, Simone Michelan-Duarte, Renata Krogh, Fernando Bezerra Romualdo da Silva, Fábio Cardoso Cruz, Aldo Sena de Oliveira, Adriano Defini Andricopulo and Luiz Carlos DiasFuture Medicinal Chemistry 16 (3) 253 (2024)
https://doi.org/10.4155/fmc-2023-0185
Nature-derived Peptides as Promising Antiparasitic Agents against Neglected Tropical Diseases
Jia Yee Lim and Keng Yoon YeongInternational Journal of Peptide Research and Therapeutics 30 (5) (2024)
https://doi.org/10.1007/s10989-024-10626-6
From proteome to candidate vaccines: target discovery and molecular dynamics-guided multi-epitope vaccine engineering against kissing bug
Faisal F. Albaqami, Ali Altharawi, Hassan N. Althurwi and Khalid M. AlharthyFrontiers in Immunology 15 (2024)
https://doi.org/10.3389/fimmu.2024.1413893
Treatment options applied to the preclinical studies using animal models for Chagas Disease: a systematic review and meta-analysis
Laura Yesenia Machaca-Luque, Mayron Antonio Candia-Puma, Brychs Milagros Roque-Pumahuanca, Haruna Luz Barazorda-Ccahuana, Luis Daniel Goyzueta-Mamani, Alexsandro Sobreira Galdino, Ricardo Andrez Machado-de-Ávila, Rodolfo Cordeiro Cordeiro Giunchetti, Eduardo Antonio Ferraz Coelho and Miguel Angel Chavez-FumagalliF1000Research 13 885 (2024)
https://doi.org/10.12688/f1000research.150723.1
Will Global Climate Change Favor the Kissing bug (Triatoma infestans)?
Ahmet AcarerUluborlu Mesleki Bilimler Dergisi 7 (3) 43 (2024)
https://doi.org/10.46236/umbd.1546075
(2024)
https://doi.org/10.1101/2024.05.30.24308159
A mathematical model for Chagas disease transmission with neighboring villages
Daniel J. Coffield, Anna Maria Spagnuolo, Ryan Capouellez and Gabrielle A. StrykerFrontiers in Applied Mathematics and Statistics 9 (2023)
https://doi.org/10.3389/fams.2023.1225137
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019
Sunny Wei, J Jamie Miranda, Mamas A Mamas, Liesl J Zühlke, Evan Kontopantelis, Lehana Thabane and Harriette G C Van SpallEuropean Heart Journal - Quality of Care and Clinical Outcomes 9 (7) 662 (2023)
https://doi.org/10.1093/ehjqcco/qcac088
Comparative microRNA profiling of Trypanosoma cruzi infected human cells
Natalia Rego, María Gabriela Libisch, Carlos Rovira, Juan Pablo Tosar and Carlos RobelloFrontiers in Cellular and Infection Microbiology 13 (2023)
https://doi.org/10.3389/fcimb.2023.1187375
From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
Daniele Cavalcante Gomes, Thayse Silva Medeiros, Eron Lincoln Alves Pereira, João Felipe Oliveira da Silva, Johny W. de Freitas Oliveira, Matheus de Freitas Fernandes-Pedrosa, Marcelo de Sousa da Silva and Arnóbio Antônio da Silva-JúniorInternational Journal of Molecular Sciences 24 (18) 13778 (2023)
https://doi.org/10.3390/ijms241813778
(2023)
https://doi.org/10.1101/2023.01.26.525677
Targeting Metalloenzymes: The “Achilles’ Heel” of Viruses and Parasites
Dimitrios Moianos, Georgia-Myrto Prifti, Maria Makri and Grigoris ZoidisPharmaceuticals 16 (6) 901 (2023)
https://doi.org/10.3390/ph16060901
Trypanosoma cruzi, Chagas disease and cancer: putting together the pieces of a complex puzzle
Cintia Daniela Kaufman, Cecilia Farré, Lucía Biscari, Ana Rosa Pérez and Andrés AlloattiFrontiers in Cell and Developmental Biology 11 (2023)
https://doi.org/10.3389/fcell.2023.1260423
Contextual influence on poor self-rated health in patients with Chagas disease: multilevel study
Ariela Mota Ferreira, Ester Cerdeira Sabino, Léa Campos de Oliveira-da Silva, et al.Ciência & Saúde Coletiva 27 (7) 2827 (2022)
https://doi.org/10.1590/1413-81232022277.01682022
New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase
Christian Espinosa-Bustos, Mariana Ortiz Pérez, Alonzo Gonzalez-Gonzalez, Ana María Zarate, Gildardo Rivera, Javier A. Belmont-Díaz, Emma Saavedra, Mauricio A. Cuellar, Karina Vázquez and Cristian O. SalasPharmaceutics 14 (6) 1121 (2022)
https://doi.org/10.3390/pharmaceutics14061121
Frequency of Human Papillomavirus Detection in Chagasic Megaesophagus Associated or Not with Esophageal Squamous Cell Carcinoma
Fernanda Franco Munari, Laura Sichero, Adriana Cruvinel Carloni, et al.Pathobiology 89 (1) 29 (2022)
https://doi.org/10.1159/000518697
Amazon Rainforest: A Natural Source for New Therapeutic Alternatives against Neglected Tropical Diseases
Soraya da Silva Santos, João Vitor Silva, Pone Kamdem Boniface and Jeanine GiarollaThe Natural Products Journal 12 (6) (2022)
https://doi.org/10.2174/2210315512666220228151415
Climate change and the prevention of cardiovascular disease
Alan P. Jacobsen, Yii Chun Khiew, Eamon Duffy, James O'Connell, Evans Brown, Paul G. Auwaerter, Roger S. Blumenthal, Brian S. Schwartz and John William McEvoyAmerican Journal of Preventive Cardiology 12 100391 (2022)
https://doi.org/10.1016/j.ajpc.2022.100391
Crystal structure of Trypanosoma cruzi heme peroxidase and characterization of its substrate specificity and compound I intermediate
Samuel L. Freeman, Vera Skafar, Hanna Kwon, Alistair J. Fielding, Peter C.E. Moody, Alejandra Martínez, Federico M. Issoglio, Lucas Inchausti, Pablo Smircich, Ari Zeida, Lucía Piacenza, Rafael Radi and Emma L. RavenJournal of Biological Chemistry 298 (8) 102204 (2022)
https://doi.org/10.1016/j.jbc.2022.102204
Chagas Disease Ecology in the United States: Recent Advances in Understanding Trypanosoma cruzi Transmission Among Triatomines, Wildlife, and Domestic Animals and a Quantitative Synthesis of Vector–Host Interactions
Rachel E. Busselman and Sarah A. HamerAnnual Review of Animal Biosciences 10 (1) 325 (2022)
https://doi.org/10.1146/annurev-animal-013120-043949
Editorial: Signaling in stress sensing and resistance in parasitic protozoa
Arijit Bhattacharya, Christopher Fernandez-Prada, Guillermo Daniel Alonso and Arunima BiswasFrontiers in Cellular and Infection Microbiology 12 (2022)
https://doi.org/10.3389/fcimb.2022.962047
Impact of IFN-γ Deficiency on the Cardiomyocyte Function in the First Stage of Experimental Chagas Disease
Danilo Roman-Campos, Policarpo Sales-Junior, Alexandre D. Costa, Diego Santos Souza, Artur Santos-Miranda, Julliane V. Joviano-Santos, Catherine Ropert and Jader S. CruzMicroorganisms 10 (2) 271 (2022)
https://doi.org/10.3390/microorganisms10020271
Development of 3D-QSAR and pharmacophoric models to design new anti-Trypanosoma cruzi agents based on 2-aryloxynaphthoquinone scaffold
M. Paulino, C. Espinosa-Bustos, J. Bertrand, et al.SAR and QSAR in Environmental Research 33 (9) 701 (2022)
https://doi.org/10.1080/1062936X.2022.2120069
New benzimidazolequinones as trypanosomicidal agents
Claudia López-Lira, Ricardo A. Tapia, Alejandra Herrera, Michel Lapier, Juan D. Maya, Jorge Soto-Delgado, Allen G. Oliver, A. Graham Lappin and Eugenio UriarteBioorganic Chemistry 111 104823 (2021)
https://doi.org/10.1016/j.bioorg.2021.104823
Cohort profile update: the main and new findings from the SaMi-Trop Chagas cohort
Claudia Di Lorenzo Oliveira, Clareci Silva Cardoso, Nayara Ragi Baldoni, et al.Revista do Instituto de Medicina Tropical de São Paulo 63 (2021)
https://doi.org/10.1590/s1678-9946202163075
Diaminomaleonitrile Derivatives as new Potential Antichagasic Compounds: A Study of Structure–Activity Relationships
Aldo S de Oliveira, Lucas dos S Mello, Camila H Ogihara, Thiago H Döring, David L Palomino-Salcedo, Simone Michelan-Duarte, Leonardo LG Ferreira, Julia M Souza, María José Dávila-Rodríguez, José W da Cruz Júnior, Edward R Dockal and Adriano D AndricopuloFuture Medicinal Chemistry 13 (24) 2167 (2021)
https://doi.org/10.4155/fmc-2021-0194
Chemical and biological analysis of 4-acyloxy-3-nitrocoumarins as trypanocidal agents
Francisco Salgado, Mauricio Moncada-Basualto, Josue Pozo-Martinez, Ana Liempi, Ulrike Kemmerling, Juan-Diego Maya, Pablo Jaque, Fernanda Borges, Eugenio Uriarte, Maria J. Matos and Claudio Olea-AzarArabian Journal of Chemistry 14 (3) 102975 (2021)
https://doi.org/10.1016/j.arabjc.2020.102975
A Rapid Review on the Efficacy and Safety of Pharmacological Treatments for Chagas Disease
Cody J Malone, Immaculate Nevis, Eduardo Fernández and Ana SanchezTropical Medicine and Infectious Disease 6 (3) 128 (2021)
https://doi.org/10.3390/tropicalmed6030128
Antikinetoplastid Activity of Sesquiterpenes Isolated from the Zoanthid Palythoa aff. clavata
Carlos J. Bethencourt-Estrella, Nathalia Nocchi, Atteneri López-Arencibia, Desirée San Nicolás-Hernández, María L. Souto, Blanca Suárez-Gómez, Ana R. Díaz-Marrero, José J. Fernández, Jacob Lorenzo-Morales and José E. PiñeroPharmaceuticals 14 (11) 1095 (2021)
https://doi.org/10.3390/ph14111095
Immunomodulation and Antioxidant Activities as Possible Trypanocidal and Cardioprotective Mechanisms of Major Terpenes from Lippia alba Essential Oils in an Experimental Model of Chronic Chagas Disease
Denerieth Ximena Espinel-Mesa, Clara Isabel González Rugeles, Julio César Mantilla Hernández, Elena E. Stashenko, Carlos Andrés Villegas-Lanau, John Jaime Quimbaya Ramírez and Liliana Torcoroma García SánchezAntioxidants 10 (11) 1851 (2021)
https://doi.org/10.3390/antiox10111851
Ficolin‐3 in chronic Chagas disease: Low serum levels associated with the risk of cardiac insufficiency
Kárita Cláudia Freitas Lidani, Fabiana Antunes Andrade, Marcia Holsbach Beltrame, Indira Chakravarti, Maria Regina Tizzot, Edneia Oliveira Cavalcanti, Thaisa Lucas Sandri, Paola Rosa Luz and Iara J. Messias‐ReasonParasite Immunology 43 (6) (2021)
https://doi.org/10.1111/pim.12829
In vitro studies and preclinical evaluation of benznidazole microparticles in the acute Trypanosoma cruzi murine model
Marcela S. Rial, Katia P. Seremeta, Mónica I. Esteva, et al.Parasitology 148 (5) 566 (2021)
https://doi.org/10.1017/S0031182020002310
A Fluorinated Phenylbenzothiazole Arrests the Trypanosoma cruzi Cell Cycle and Diminishes the Infection of Mammalian Host Cells
Roberto I. Cuevas-Hernández, Richard M. B. M. Girard, Sarai Martínez-Cerón, et al.Antimicrobial Agents and Chemotherapy 64 (2) (2020)
https://doi.org/10.1128/AAC.01742-19
Factors associated with Chagas screening among immigrants from an endemic country in Madrid, Spain
María Romay-Barja, Teresa Boquete, Obdulia Martinez, et al.PLOS ONE 15 (3) e0230120 (2020)
https://doi.org/10.1371/journal.pone.0230120
Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project
Nayara Dornela Quintino, Ester Cerdeira Sabino, José Luiz Padilha da Silva, et al.PLOS Neglected Tropical Diseases 14 (5) e0008144 (2020)
https://doi.org/10.1371/journal.pntd.0008144
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacy
Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Amanda F. Francisco, John M. Kelly, Jennifer Riley, Kevin D. Read, Catherine J. Perez, Scott Cornwall, R.C. Andrew Thompson, Martine Keenan, Karen L. White, Susan A. Charman, Bilal Zulfiqar, Melissa L. Sykes, Vicky M. Avery, Eric Chatelain and William A. DennyEuropean Journal of Medicinal Chemistry 207 112849 (2020)
https://doi.org/10.1016/j.ejmech.2020.112849
Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
Gurdip Singh Mann, Amanda F. Francisco, Shiromani Jayawardhana, et al.PLOS Neglected Tropical Diseases 14 (4) e0007717 (2020)
https://doi.org/10.1371/journal.pntd.0007717
Mixed infections by different Trypanosoma cruzi discrete typing units among Chagas disease patients in an endemic community in Panama
Alexa Prescilla Ledezma, Roberto Blandon, Alejandro G. Schijman, et al.PLOS ONE 15 (11) e0241921 (2020)
https://doi.org/10.1371/journal.pone.0241921
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review
Soraya Silva Santos, Renan Vinicius de Araújo, Jeanine Giarolla, Omar El Seoud and Elizabeth Igne FerreiraInternational Journal of Antimicrobial Agents 55 (4) 105906 (2020)
https://doi.org/10.1016/j.ijantimicag.2020.105906
Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases
Hollis D. ShowalterMolecules 25 (18) 4137 (2020)
https://doi.org/10.3390/molecules25184137
Performance Evaluation of a Commercial Real-Time PCR Assay and of an In-House Real-Time PCR for Trypanosoma cruzi DNA Detection in a Tropical Medicine Reference Center, Northern Italy
Silvia Stefania Longoni, Elena Pomari, Alberto Antonelli, Fabio Formenti, Ronaldo Silva, Stefano Tais, Salvatore Scarso, Gian Maria Rossolini, Andrea Angheben and Francesca PerandinMicroorganisms 8 (11) 1692 (2020)
https://doi.org/10.3390/microorganisms8111692
Benznidazole as Prophylaxis for Chagas Disease Infection Reactivation in Heart Transplant Patients: A Case Series in Brazil
Joao Manoel Rossi Neto, Marco Aurelio Finger and Carolina Casadei dos SantosTropical Medicine and Infectious Disease 5 (3) 132 (2020)
https://doi.org/10.3390/tropicalmed5030132
MicroRNAs: Biological Regulators in Pathogen–Host Interactions
Stephanie Maia Acuña, Lucile Maria Floeter-Winter and Sandra Marcia MuxelCells 9 (1) 113 (2020)
https://doi.org/10.3390/cells9010113
Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
Claudia Di Lorenzo Oliveira, Maria Carmo P. Nunes, Enrico Antonio Colosimo, Emilly Malveira de Lima, Clareci S. Cardoso, Ariela Mota Ferreira, Lea Campos de Oliveira, Carlos Henrique Valente Moreira, Ana Luiza Bierrenbach, Desireé Sant′Ana Haikal, Sérgio Viana Peixoto, Maria Fernanda Lima‐Costa, Ester Cerdeira Sabino and Antonio Luiz P. RibeiroJournal of the American Heart Association 9 (6) (2020)
https://doi.org/10.1161/JAHA.119.014176
A Trypanosoma cruzi Genome Tandem Repetitive Satellite DNA Sequence as a Molecular Marker for a LAMP Assay for Diagnosing Chagas’ Disease
Diego Ordóñez, Pedro Fernández-Soto, Ana M. Fernández-Martín, et al.Disease Markers 2020 1 (2020)
https://doi.org/10.1155/2020/8074314
Diversity and genome mapping assessment of disordered and functional domains in trypanosomatids
Grace Santos Tavares Avelar, Leilane Oliveira Gonçalves, Frederico Gonçalves Guimarães, Paul Anderson Souza Guimarães, Luiz Gustavo do Nascimento Rocha, Maria Gabriela Reis Carvalho, Daniela de Melo Resende and Jeronimo Conceição RuizJournal of Proteomics 227 103919 (2020)
https://doi.org/10.1016/j.jprot.2020.103919
540 (2020)
https://doi.org/10.1109/EIT48999.2020.9208261
Role of FAK signaling in chagasic cardiac hypertrophy
Amanda R. Tucci, Francisco O. R. de Oliveira, Guilherme C. Lechuga, Gabriel M. Oliveira, Ana Carolina Eleuterio, Liliane B. de Mesquita, Priscila S.G. Farani, Constança Britto, Otacílio C. Moreira and Mirian Claudia S. PereiraThe Brazilian Journal of Infectious Diseases 24 (5) 386 (2020)
https://doi.org/10.1016/j.bjid.2020.08.007
Foregut Surgery
Leonardo M. Del Grande and Fernando A. M. HerbellaForegut Surgery 23 (2020)
https://doi.org/10.1007/978-3-030-27592-1_3
Increased frequencies of circulating CCR5+ memory T cells are correlated to chronic chagasic cardiomyopathy progression
Ester Roffe, Luara I Dos Santos, Maykon O Santos, et al.Journal of Leukocyte Biology 106 (3) 641 (2019)
https://doi.org/10.1002/JLB.MA1118-472R
Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
Ana Catarina Cristovão Silva, Maria Carolina Accioly Brelaz-de-Castro, Ana Cristina Lima Leite, Valéria Rêgo Alves Pereira and Marcelo Zaldini HernandesFrontiers in Pharmacology 10 (2019)
https://doi.org/10.3389/fphar.2019.00873
(2019)
https://doi.org/10.1101/2019.12.25.19015776
Advances in understanding the role of adipose tissue and mitochondrial oxidative stress in Trypanosoma cruzi infection
Jyothi F. Nagajyothi and Louis M. WeissF1000Research 8 1152 (2019)
https://doi.org/10.12688/f1000research.19190.1
The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
Carlos Robello, Doris Patricia Maldonado, Anna Hevia, et al.PLOS ONE 14 (2) e0212593 (2019)
https://doi.org/10.1371/journal.pone.0212593
A reduction in ecological niche for Trypanosoma cruzi-infected triatomine bugs
Guiehdani Villalobos, Angela Nava-Bolaños, José A. De Fuentes-Vicente, et al.Parasites & Vectors 12 (1) (2019)
https://doi.org/10.1186/s13071-019-3489-5
Potential Utility of Protein Targets of Cysteine-S-Nitrosylation in Identifying Clinical Disease Status in Human Chagas Disease
Maria Paola Zago, John E. Wiktorowicz, Heidi Spratt, et al.Frontiers in Microbiology 9 (2019)
https://doi.org/10.3389/fmicb.2018.03320
Glucocorticoids and sympathetic neurotransmitters modulate the acute immune response to Trypanosoma cruzi
Eduardo Roggero, Adriana del Rey, Johannes Wildmann and Hugo BesedovskyAnnals of the New York Academy of Sciences 1437 (1) 83 (2019)
https://doi.org/10.1111/nyas.13946
Trypanosoma cruzi immunoproteome: Calpain-like CAP5.5 differentially detected throughout distinct stages of human Chagas disease cardiomyopathy
Marcelle A. Caminha, Virginia Maria B. de Lorena, Wilson de Oliveira Júnior, Jonas Perales, Paulo C. Carvalho, Diogo B. Lima, Maria da Glória A.M. Cavalcanti, Sílvia M. Martins, Richard H. Valente and Rubem F.S. Menna-BarretoJournal of Proteomics 194 179 (2019)
https://doi.org/10.1016/j.jprot.2018.11.019
Chagas disease as example of a reemerging parasite
Jeannette GuarnerSeminars in Diagnostic Pathology 36 (3) 164 (2019)
https://doi.org/10.1053/j.semdp.2019.04.008
A Combination of Itraconazole and Amiodarone Is Highly Effective against Trypanosoma cruzi Infection of Human Stem Cell–Derived Cardiomyocytes
Gabriele Sass, Roy T. Madigan, Lydia-Marie Joubert, et al.The American Journal of Tropical Medicine and Hygiene 101 (2) 383 (2019)
https://doi.org/10.4269/ajtmh.19-0023
(2019)
https://doi.org/10.1101/741462
Inhibition of C. albicans Dimorphic Switch by Cobalt(II) Complexes with Ligands Derived from Pyrazoles and Dinitrobenzoate: Synthesis, Characterization and Biological Activity
Daniela Fonseca, Sandra M. Leal-Pinto, Martha V. Roa-Cordero, José D. Vargas, Erika M. Moreno-Moreno, Mario A. Macías, Leopoldo Suescun, Álvaro Muñoz-Castro and John J. HurtadoInternational Journal of Molecular Sciences 20 (13) 3237 (2019)
https://doi.org/10.3390/ijms20133237
Elucidating diversity in the class composition of the minicircle hypervariable region of Trypanosoma cruzi: New perspectives on typing and kDNA inheritance
Fanny Rusman, Nicolás Tomasini, Noelia-Floridia Yapur, et al.PLOS Neglected Tropical Diseases 13 (6) e0007536 (2019)
https://doi.org/10.1371/journal.pntd.0007536
Parasitic Diseases Within the Spinal Cord and Nerve Roots
Benjamin Rahmani, Shrey Patel, Omar Seyam, et al.SN Comprehensive Clinical Medicine 1 (11) 869 (2019)
https://doi.org/10.1007/s42399-019-00156-4
Community-based surveillance and control of chagas disease vectors in remote rural areas of the Argentine Chaco: A five-year follow-up
María C. Cecere, Lucía I. Rodríguez-Planes, Gonzalo M. Vazquez-Prokopec, Uriel Kitron and Ricardo E. GürtlerActa Tropica 191 108 (2019)
https://doi.org/10.1016/j.actatropica.2018.12.038
Chagas Disease: From Discovery to a Worldwide Health Problem
Kárita Cláudia Freitas Lidani, Fabiana Antunes Andrade, Lorena Bavia, et al.Frontiers in Public Health 7 (2019)
https://doi.org/10.3389/fpubh.2019.00166
Early Trypanosoma cruzi Infection Triggers mTORC1-Mediated Respiration Increase and Mitochondrial Biogenesis in Human Primary Cardiomyocytes
M. Gabriela Libisch, Paula Faral-Tello, Nisha J. Garg, et al.Frontiers in Microbiology 9 (2018)
https://doi.org/10.3389/fmicb.2018.01889
Foodborne Parasites
Charles R. SterlingFoodborne Parasites 17 (2018)
https://doi.org/10.1007/978-3-319-67664-7_2
Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis
Lyda Z. Rojas, Marija Glisic, Laura Pletsch-Borba, et al.PLOS Neglected Tropical Diseases 12 (6) e0006567 (2018)
https://doi.org/10.1371/journal.pntd.0006567
Molecular description of α‐keto‐based inhibitors of cruzain with activity against Chagas disease combining 3D‐QSAR studies and molecular dynamics
Ádria P. B. Saraiva, Ricardo M. Miranda, Renan P. P. Valente, Jéssica O. Araújo, Rutelene N. B. Souza, Clauber H. S. Costa, Amanda R. S. Oliveira, Michell O. Almeida, Antonio F. Figueiredo, João E. V. Ferreira, Cláudio Nahum Alves and Kathia M. HonorioChemical Biology & Drug Design 92 (2) 1475 (2018)
https://doi.org/10.1111/cbdd.13313
Pyrazinoates as antiparasitic agents against Trypanosoma cruzi
Camilla I. Vasconcelos, Marina T. Varela, Ana C. Torrecilhas and João P. S. FernandesArchiv der Pharmazie 351 (11) (2018)
https://doi.org/10.1002/ardp.201800190
Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease
Maiara Voltarelli Providello, Zumira Aparecida Carneiro, Gisele Bulhões Portapilla, et al.Antimicrobial Agents and Chemotherapy 62 (9) (2018)
https://doi.org/10.1128/AAC.00514-18
The Trypanosoma cruzi RNA-binding protein RBP42 is expressed in the cytoplasm throughout the life cycle of the parasite
R. Tyler Weisbarth, Anish Das, Paul Castellano, et al.Parasitology Research 117 (4) 1095 (2018)
https://doi.org/10.1007/s00436-018-5787-9
Are the London Declaration’s 2020 goals sufficient to control Chagas disease?: Modeling scenarios for the Yucatan Peninsula
Bruce Y. Lee, Sarah M. Bartsch, Laura Skrip, et al.PLOS Neglected Tropical Diseases 12 (3) e0006337 (2018)
https://doi.org/10.1371/journal.pntd.0006337
Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades
Silvia Fabiani, Simona Fortunato and Fabrizio BruschiPathogens 7 (3) 65 (2018)
https://doi.org/10.3390/pathogens7030065
2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas’ disease
Michael G. Thomas, Manu De Rycker, Ignacio Cotillo Torrejon, John Thomas, Jennifer Riley, Daniel Spinks, Kevin D. Read, Tim J. Miles, Ian H. Gilbert and Paul G. WyattBioorganic & Medicinal Chemistry Letters 28 (18) 3025 (2018)
https://doi.org/10.1016/j.bmcl.2018.08.005
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease
Christopher A. Seid, Kathryn M. Jones, Jeroen Pollet, et al.Human Vaccines & Immunotherapeutics 13 (3) 621 (2017)
https://doi.org/10.1080/21645515.2016.1242540
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.Journal of Medicinal Chemistry 60 (17) 7284 (2017)
https://doi.org/10.1021/acs.jmedchem.7b00463
Sylvatic host associations of Triatominae and implications for Chagas disease reservoirs: a review and new host records based on archival specimens
Anna Y. Georgieva, Eric R.L. Gordon and Christiane WeirauchPeerJ 5 e3826 (2017)
https://doi.org/10.7717/peerj.3826
Eco-social processes influencing infectious disease emergence and spread
BRYONY A. JONES, MARTHA BETSON and DIRK U. PFEIFFERParasitology 144 (1) 26 (2017)
https://doi.org/10.1017/S0031182016001414
Antitrypanosomal activity and evaluation of the mechanism of action of dehydrodieugenol isolated from Nectandra leucantha (Lauraceae) and its methylated derivative against Trypanosoma cruzi
Simone S. Grecco, Thais A. Costa-Silva, Gerold Jerz, et al.Phytomedicine 24 62 (2017)
https://doi.org/10.1016/j.phymed.2016.11.015
6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases
Andrew M. Thompson, Adrian Blaser, Brian D. Palmer, Robert F. Anderson, Sujata S. Shinde, Delphine Launay, Eric Chatelain, Louis Maes, Scott G. Franzblau, Baojie Wan, Yuehong Wang, Zhenkun Ma and William A. DennyBioorganic & Medicinal Chemistry Letters 27 (11) 2583 (2017)
https://doi.org/10.1016/j.bmcl.2017.03.069
Lysosomes - Associated Diseases and Methods to Study Their Function
Barbara Hissa and Luciana O. AndradeLysosomes - Associated Diseases and Methods to Study Their Function (2017)
https://doi.org/10.5772/intechopen.69305